Quadrant Capital Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$227K Buy
13,277
+12,706
+2,225% +$217K 0.01% 1252
2025
Q1
$36.4K Sell
571
-271
-32% -$17.3K ﹤0.01% 1831
2024
Q4
$102K Sell
842
-24
-3% -$2.92K 0.01% 1037
2024
Q3
$108K Buy
866
+303
+54% +$37.8K 0.01% 1024
2024
Q2
$89K Buy
563
+482
+595% +$76.2K 0.01% 1078
2024
Q1
$10.5K Buy
81
+12
+17% +$1.55K ﹤0.01% 2088
2023
Q4
$6.65K Buy
69
+31
+82% +$2.99K ﹤0.01% 2199
2023
Q3
$4.61K Buy
38
+1
+3% +$121 ﹤0.01% 2198
2023
Q2
$4.24K Sell
37
-90
-71% -$10.3K ﹤0.01% 2244
2023
Q1
$17.5K Buy
127
+95
+297% +$13.1K ﹤0.01% 1760
2022
Q4
$4.15K Sell
32
-25
-44% -$3.24K ﹤0.01% 2246
2022
Q3
$6K Sell
57
-89
-61% -$9.37K ﹤0.01% 2094
2022
Q2
$11K Sell
146
-163
-53% -$12.3K ﹤0.01% 1623
2022
Q1
$24K Sell
309
-465
-60% -$36.1K ﹤0.01% 1251
2021
Q4
$70K Sell
774
-7
-0.9% -$633 0.01% 793
2021
Q3
$72K Buy
781
+600
+331% +$55.3K 0.01% 736
2021
Q2
$14K Buy
181
+142
+364% +$11K ﹤0.01% 1400
2021
Q1
$3K Sell
39
-33
-46% -$2.54K ﹤0.01% 1988
2020
Q4
$12K Buy
72
+30
+71% +$5K ﹤0.01% 1312
2020
Q3
$6K Sell
42
-3
-7% -$429 ﹤0.01% 1484
2020
Q2
$7K Sell
45
-186
-81% -$28.9K ﹤0.01% 1518
2020
Q1
$22K Buy
231
+218
+1,677% +$20.8K ﹤0.01% 1242
2019
Q4
$1K Buy
+13
New +$1K ﹤0.01% 2353
2019
Q3
Sell
-389
Closed -$58K 2382
2019
Q2
$58K Sell
389
-52
-12% -$7.75K 0.01% 1149
2019
Q1
$51K Buy
+441
New +$51K 0.01% 1208
2018
Q4
Sell
-6
Closed 2287
2018
Q3
$0 Buy
+6
New ﹤0.01% 2185